Inaktiver Wert

Transkripte GTx, Inc. Nasdaq

Aktien

US40052B2079

Transkripte

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Transcript : Oncternal Therapeutics, Inc. - Special Call	19.03.
Transcript : Oncternal Therapeutics, Inc., Q4 2023 Earnings Call, Mar 07, 2024	07.03.
Transcript : Oncternal Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023	09.11.
Transcript : Oncternal Therapeutics, Inc., Q2 2023 Earnings Call, Aug 10, 2023	10.08.23
Transcript : Oncternal Therapeutics, Inc., Q1 2023 Earnings Call, May 04, 2023	04.05.23
Transcript : Oncternal Therapeutics, Inc. - Special Call	18.04.23
Transcript : Oncternal Therapeutics, Inc. - Shareholder/Analyst Call	03.04.23
Transcript : Oncternal Therapeutics, Inc., Q4 2022 Earnings Call, Mar 09, 2023	09.03.23
Transcript : Oncternal Therapeutics, Inc., Q3 2022 Earnings Call, Nov 03, 2022	03.11.22
Transcript : Oncternal Therapeutics, Inc., Q2 2022 Earnings Call, Aug 09, 2022	09.08.22
Transcript : Oncternal Therapeutics, Inc. - Special Call	22.06.22
Transcript : Oncternal Therapeutics, Inc., Q1 2022 Earnings Call, May 05, 2022	05.05.22
Transcript : Oncternal Therapeutics, Inc., Q4 2021 Earnings Call, Mar 10, 2022	10.03.22
Transcript : Oncternal Therapeutics, Inc. - Special Call	25.01.22
Transcript : Oncternal Therapeutics, Inc. - Special Call	04.01.22
Transcript : Oncternal Therapeutics, Inc., Q3 2021 Earnings Call, Nov 04, 2021	04.11.21
Transcript : Oncternal Therapeutics, Inc., Q2 2021 Earnings Call, Aug 05, 2021	05.08.21
Transcript : Oncternal Therapeutics, Inc., Q1 2021 Earnings Call, May 06, 2021	06.05.21
Transcript : Oncternal Therapeutics, Inc., Q4 2020 Earnings Call, Mar 11, 2021	11.03.21
Transcript : Oncternal Therapeutics, Inc., Q2 2020 Earnings Call, Aug 06, 2020	06.08.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Transkripte GTx, Inc. Nasdaq

Aktien

US40052B2079

Transkripte

Filter